Antimicrobial resistance is the ability of bacteria, fungi, viruses, or parasites to survive drugs that once controlled them. In practice, AMR turns standard treatment into a probabilistic problem: a drug may work against one strain and fail against another, even within the same species.
AMR matters in cyber security because modern healthcare depends on software, data, and networked devices to support treatment decisions. Clinical decision support tools, lab systems, and predictive models must use accurate microbiology data and up-to-date resistance patterns. If records are altered, mislabeled, or drift out of date, software can recommend the wrong therapy or mis-rank risk. Defenders treat AMR-aware systems like safety-critical pipelines: they need strong access control, audit logs, data validation, and continuous monitoring. In real defenses, AMR drives the use of antimicrobial susceptibility testing as the reference point, with software serving as an assistive layer rather than a replacement.